Pyridine,3,3'-(1,3,4-oxadiazole-2,5-diyl)bis-

Suppliers

Names

[ CAS No. ]:
15420-57-2

[ Name ]:
Pyridine,3,3'-(1,3,4-oxadiazole-2,5-diyl)bis-

[Synonym ]:
3,3'-[1,3,4]oxadiazole-2,5-diyl-bis-pyridine
3-(5-pyridin-3-yl-[1,3,4]oxadiazol-2-yl)-pyridine
2,5-bis-(3-pyridyl)-1,3,4-oxadiazole
3,3'-(1,3,4-Oxadiazol-2,5-ylene)dipyridine
1,3,4-Oxadiazole,2,5-di-3-pyridyl
Pyridine,3,3'-(1,3,4-oxadiazole-2,5-diyl)bis
2,5-di(pyridin-3-yl)-1,3,4-oxadiazole
Pyridine,3,3'-(1,3,4-oxadiazol-2,5-ylene)di
2,4-DICHLORO-5-FLUOROANLINE
2-(3''-pyridinyl)-5-(3'-pyridinyl)-1,3,4-oxadiazole
3,3'-(1,3,4-oxadiazole-2,5-diyl)dipyridine

Chemical & Physical Properties

[ Density]:
1.276g/cm3

[ Boiling Point ]:
438.9ºC at 760mmHg

[ Molecular Formula ]:
C12H8N4O

[ Molecular Weight ]:
224.21800

[ Flash Point ]:
229.3ºC

[ Exact Mass ]:
224.07000

[ PSA ]:
64.70000

[ LogP ]:
2.19360

[ Vapour Pressure ]:
1.72E-07mmHg at 25°C

[ Index of Refraction ]:
1.599

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
UT6402000
CHEMICAL NAME :
Pyridine, 3,3'-(1,3,4-oxadiazol-2,5-ylene)di-
CAS REGISTRY NUMBER :
15420-57-2
LAST UPDATED :
199803
DATA ITEMS CITED :
1
MOLECULAR FORMULA :
C12-H8-N4-O
MOLECULAR WEIGHT :
224.24
WISWESSER LINE NOTATION :
T6NJ C- CT5NN DOJ E- CT6NJ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
448 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
PHARAT Pharmazie. (VEB Verlag Volk und Gesundheit, Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1946- Volume(issue)/page/year: 39,858,1984

Safety Information

[ HS Code ]:
2934999090

Synthetic Route

Click to get detail synthetic route

Customs

[ HS Code ]: 2934999090

[ Summary ]:
2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Related Compounds

  • Pyridine,3,3'-(1,3,4-oxadiazole-2,5-diyl)bis-,(2E)-2-butenedioate (1:1)
  • Benzenamine, 3,3'-(1,3,4-oxadiazole-2,5-diyl)bis[2,4,6-trinitro-
  • diethyl 3,3'-(1,3,4-oxadiazole-2,5-diyl)dibenzoate
  • 2,5-di(pyrazin-2-yl)-1,3,4-oxadiazole
  • 4-[5-(4-carbonochloridoylphenyl)-1,3,4-oxadiazol-2-yl]benzoyl chloride
  • methyl 4-[5-(4-methoxycarbonylphenyl)-1,3,4-oxadiazol-2-yl]benzoate
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • [2,2-Difluoro-1-(2-methyl-1-phenylpropyl)cyclopropyl]methanamine
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
  • tert-Butyl-DL-alanine
  • 4-amino-N-[2-tert-butyl-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-benzimidazol-5-yl]-N-ethylbenzenesulfonamide